Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.65
Delayed Data
As of May 22
 -0.15 / -3.95%
Today’s Change
2.35
Today|||52-Week Range
4.49
+48.98%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.80
Today’s open3.85
Day’s range3.55 - 3.85
Volume156,073
Average volume (3 months)202,699
Market cap$209.1M
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+78.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
CORICorium International...-0.31-4.53%
URGNUrogen Pharma Ltd+0.05+0.27%
MDGLMadrigal Pharmaceuti...+0.10+0.61%
CEMPCempra Inc+0.05+1.32%
Data as of 3:59pm ET, 05/22/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts